Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease.

scientific article

Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/AJMG.10515
P698PubMed publication ID12116197

P50authorEliecer CotoQ91531533
Ignacio F MataQ40102964
P2093author name stringCarmen Martínez
Victoria Alvarez
Ignacio F Mata
Pelayo González
Carlos H Lahoz
Joaquín Peña
Luis M Guisasola
P2860cites workInflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.Q51981238
A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.Q53228560
Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03.Q53231515
TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.Q53235705
Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphismQ58452081
Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian populationQ71547126
Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathologyQ73807424
Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphismQ73873232
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
A simple salting out procedure for extracting DNA from human nucleated cellsQ27861086
Inflammation and Alzheimer's diseaseQ28138617
Dual role of tumor necrosis factor alpha in brain injuryQ33879032
Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.Q33900383
The role of TNF and its receptors in Alzheimer's diseaseQ34469501
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activationQ36082965
Risk of Alzheimer's disease and duration of NSAID use.Q39457609
Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35].Q40946540
A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsisQ40949167
The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.Q41117030
Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics InitiativeQ44267597
Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alphaQ47885336
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malariaQ48009520
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementiaQ48121615
TNF alpha gene expression is induced in neurones after a hippocampal lesion.Q48187813
TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.Q48778348
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control studyQ48939488
P433issue5
P921main subjectAlzheimer's diseaseQ11081
P304page(s)574-577
P577publication date2002-07-01
P1433published inAmerican Journal of Medical Genetics Part AQ15755121
P1476titleAssociation between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease.
P478volume114

Reverse relations

cites work (P2860)
Q53303396APOE epsilon-4 allele and cytokine production in Alzheimer's disease.
Q53361330Association between TNF-α promoter -308 A/G polymorphism and Alzheimer's disease: a meta-analysis.
Q36882004Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
Q37083159Association of tumor necrosis factor-α gene polymorphism (-308) and obstructive sleep apnea-hypopnea syndrome
Q36718053Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
Q47579780Characterisation of amyloid-induced inflammatory responses in the rat retina
Q33654621Commonly studied polymorphisms in inflammatory cytokine genes show only minor effects on mortality and related risk factors in nonagenarians
Q78344719Current awareness in geriatric psychiatry
Q23910386Cytokine polymorphisms and relationship to disease
Q58549216Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review
Q41850092Functional inflammatory genotypes in ischemic stroke: could we use them to predict age of onset and long-term outcome?
Q41136953Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
Q35686013Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran
Q38018496Genetic determinants of neuronal vulnerability to apoptosis.
Q54485999Human cytokine response to ex vivo amyloid-beta stimulation is mediated by genetic factors.
Q36571241Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population.
Q36600561Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.
Q37762260Perispinal etanercept: a new therapeutic paradigm in neurology
Q38050498Review: systemic inflammation and Alzheimer's disease
Q37954456Systemic and central immunity in Alzheimer's disease: therapeutic implications
Q53269691TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Q38970893Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease
Q58045474The ageing immune system and its clinical implications
Q53304397The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
Q54739818Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia.
Q22241425Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease

Search more.